Greedy Insider
TRDA Insider Trades and Greediness Scores
Entrada Therapeutics, Inc. (TRDA) insider trades: since Mar 2, 2026, Greedy Insider recorded 1 open-market buys and 53 sales on Form 4 from 9 insiders. The strongest recent filing scored 86 (Strong).
Who bought and who sold
Across the last 54 scoreable Form 4 transactions in TRDA, 1 were open-market purchases and 53 were sales. The table lists the most recent filings with each one's Greediness Score, so the structurally unusual trades are easy to spot first.
| Insider | Role | Type | Shares | Date | Score | ||
|---|---|---|---|---|---|---|---|
| MPM BioVentures 2014, L.P. | 10% owner | Sell | 28837.0 | 205607.81 | 2026-09-09 | 65 | View |
| MPM BIOVENTURES 2018, L.P. | 10% owner | Sell | 28837.0 | 205607.81 | 2026-09-09 | 65 | View |
| MPM BioVentures 2014, L.P. | 10% owner | Sell | 192500.0 | 1426425.0 | 2026-09-08 | 77 | View |
| MPM BIOVENTURES 2018, L.P. | 10% owner | Sell | 192500.0 | 1426425.0 | 2026-09-08 | 77 | View |
| MPM BioVentures 2014, L.P. | 10% owner | Sell | 38500.0 | 273735.0 | 2026-09-04 | 64 | View |
| MPM BIOVENTURES 2018, L.P. | 10% owner | Sell | 38500.0 | 273735.0 | 2026-09-04 | 64 | View |
| MPM BioVentures 2014, L.P. | 10% owner | Sell | 32263.0 | 231325.7 | 2026-09-03 | 66 | View |
| MPM BIOVENTURES 2018, L.P. | 10% owner | Sell | 32263.0 | 231325.7 | 2026-09-03 | 66 | View |
| MPM BioVentures 2014, L.P. | 10% owner | Sell | 25131.0 | 180691.89 | 2026-09-02 | 64 | View |
| MPM BIOVENTURES 2018, L.P. | 10% owner | Sell | 25131.0 | 180691.89 | 2026-09-02 | 64 | View |
The strongest recent filing
WENTWORTH KORY JAMES (CFO) sold 11,388 shares of Entrada Therapeutics, Inc. on Mar 10, 2026, a filing that scored 86 (Strong). It scored Strong because a senior insider was trading and it was direct personal ownership. The score describes the filing, not future returns. This is not investment advice.
Cluster activity
A cluster buy is present: 4 insiders (Dowden Nathan J, WENTWORTH KORY JAMES, Doshi Dipal, Sethuraman Natarajan) traded TRDA the same direction within a 7-day window. Shared conviction is a stronger structural signal than a lone trade.
How this compares with Entrada Therapeutics, Inc.'s own history
Open-market buys make up 2% of the 54 scoreable TRDA transactions on record between Mar 2, 2026 and Sep 9, 2026. Comparing a filing with the company's own buy/sell mix is how you tell a routine disposal from an unusual accumulation.
Methodology and sources
Scores come from six published, user-adjustable factors (insider role, cluster activity, trade size versus the insider's own history, position impact, filing urgency, and direct versus indirect ownership). The score describes the filing, not future returns. This is not investment advice.
Key facts
- Scoreable Form 4 transactions on record: 54
- Open-market buys: 1
- Sales: 53
- Distinct insiders: 9
- Strongest recent Greediness Score: 86 (Strong)
Primary sources
Related
- Strongest filing
- TRDA in the live feed
- How the Greediness Score works
- What is a cluster buy?
- Form 4 transaction codes
The score describes the filing, not future returns. This is not investment advice.